| 注册
首页|期刊导航|中草药|中药溯源体系全链条建设的多技术融合、发展现状、挑战及未来展望

中药溯源体系全链条建设的多技术融合、发展现状、挑战及未来展望

施明毅 唐杨丽 黄依凡 付愉岭 李娅 罗悦 温川飙

中草药2026,Vol.57Issue(16):6209-6225,17.
✕
中草药2026,Vol.57Issue(16):6209-6225,17.DOI:10.7501/j.issn.0253-2670.2026.16.001

中药溯源体系全链条建设的多技术融合、发展现状、挑战及未来展望

Multi-technology integration,development status,challenges and future prospects in full-chain construction of Chinese medicinal materials traceability system

施明毅 1唐杨丽 2黄依凡 2付愉岭 2李娅 2罗悦 2温川飙1

作者信息

  • 1. 成都中医药大学基础医学院,四川成都 611137||成都中医药大学智能医学学院,四川成都 611137
  • 2. 成都中医药大学智能医学学院,四川成都 611137
  • 折叠

摘要

Abstract

The quality and safety of Chinese medicinal materials are the lifeline for the sustainable development of the traditional Chinese medicine(TCM)industry.Establishing a traceability system for Chinese medicinal materials is a core means to solve the problem of whole-chain quality control and achieve quality supervision,which is of great significance for maintaining the brand image of authentic medicinal materials and regulating the order of the medicinal materials market.At present,China's traceability system for Chinese medicinal materials has integrated key technologies such as the Internet of Things,blockchain,big data,and AI,and has built a full-chain information management system covering"cultivation-processing-circulation-use".Pilot projects in multiple regions have verified its application value,and the industry has entered a stable development stage of multi-technology collaboration.However,existing research and practice still face key controversies and deficiencies:technical coordination problems such as large differences in information dimensions among research and development institutions and disconnected traceability information across multiple links,subject awareness problems such as weak self-supervision awareness among business operators,cost and data problems such as high information collection costs and high barriers to participation for small and medium-sized entities,and industry standardization problems such as the lack of unified national data standards and imperfect regulatory mechanisms.These issues lead to limited coverage of the traceability system,the continued existence of counterfeit and substandard medicinal materials,and an urgent need to enhance the ability to trace back to the source and recall problematic products.The purpose of this study is to systematically review the development history and policy evolution of the traceability system for Chinese medicinal materials,summarize its core functions,key technology integration application logic,and typical pilot achievements,and propose targeted optimization suggestions for current deficiencies.The research structure analyzes the problem from the"root-amplification-ultimate"logical chain of Chinese medicinal material quality safety,then elaborates on the development and construction status of the traceability system,subsequently analyzes the challenges faced and proposes feasible countermeasures,and finally looks forward to future development directions.The study finds that the construction of the traceability system for Chinese medicinal materials needs to focus on standardization,intelligence,inclusiveness,and globalization as core directions.By formulating unified metadata standards,deepening multi-technology integration,constructing a"government subsidies+insurance linkage+brand premium"cost model,and improving diversified co-governance regulatory mechanisms,industry pain points can be resolved.In the future,further focus should be placed on differentiated traceability schemes for different categories of Chinese medicinal materials,low-cost implementation paths for multi-technology integration,correlation analysis between traceability data and clinical efficacy,and other directions,to promote deep integration of academic achievements and industrial applications,making the traceability system for Chinese medicinal materials a solid support for ensuring the quality and safety of Chinese medicinal materials and promoting the inheritance,innovation,and development of TCM.

关键词

中药安全/质量监管/中药溯源/溯源体系/多技术融合/人工智能

Key words

safety of Chinese medicinal materials/quality supervision/traceability of Chinese medicinal materials/traceability system/multi-technology integration/artificial intelligence

分类

医药卫生

引用本文复制引用

施明毅,唐杨丽,黄依凡,付愉岭,李娅,罗悦,温川飙..中药溯源体系全链条建设的多技术融合、发展现状、挑战及未来展望[J].中草药,2026,57(16):6209-6225,17.

基金项目

国家自然科学基金面上项目(82174236) (82174236)

四川省高等教育人才培养质量和教学改革项目(JG2024-0660) (JG2024-0660)

四川省卫生信息学会科研课题(2025010) (2025010)

中草药

0253-2670

访问量0
|
下载量0
段落导航相关论文